Microbiome News and Research

Latest Microbiome News and Research

Probiotic bacteria may enhance anti-cancer activities of tamoxifen to reduce ER+ breast cancer risk

Probiotic bacteria may enhance anti-cancer activities of the breast cancer drug tamoxifen and other endocrine-targeted therapies, which could help reduce the risk of estrogen receptive positive (ER+) breast cancer, suggests a new study presented Monday at ENDO 2022, the Endocrine Society's annual meeting in Atlanta, Ga.

13 Jun 2022

Gut microbiome may be the "black box" of nutrition research

In a recent paper published in the Cell journal, researchers at the University of Alberta, Canada, and the University College Cork, Ireland, analyzed the current nutritional guidelines for gut microbiota.

13 Jun 2022

Abundance of Lactobacillus crispatus linked to lower risk of preterm birth

Globally, preterm birth complications are the leading cause of death for children under the age of 5. Not everyone faces the same risk, though: In the United States, roughly 10% of pregnancies lead to preterm birth, but for Black women, that likelihood is 14%.

10 Jun 2022

Study suggests the gut microbiota may be one of the factors determining the physiological inter-sex differences in pain perception

Researchers investigated whether the gut-brain axis could influence pain thresholds.

10 Jun 2022

Development of infant microbiome varies across a spectrum of lifestyles

A metagenomic comparison of the infant gut microbiota assembly from industrialized and nonindustrialized populations reveals robust and systematic lifestyle-dependent divergences, researchers report.

9 Jun 2022

Alternative remedy to conventional root canals would regenerate lost tooth pulp

Each year, dentists in the United States perform more than 15 million root canals on infected teeth, removing the inflamed pulp and filling the emptied canal with inert materials such as rubber and cement. What remains is a mineral shell in place of a living tooth.

9 Jun 2022

Gastrointestinal complications caused by SARS-CoV-2

scientists discuss the gastrointestinal complications associated with COVID-19.

7 Jun 2022

Study finds striking epigenetic differences in the airway cells of adult children born to asthmatic mothers

Asthma is a chronic condition that affects 25 million people in the United States. Having a mother with asthma is an important risk factor and a new study may explain why.

6 Jun 2022

New analytical method sheds light on enduring mystery about type 2 diabetes

Researchers at Oregon State University have invented a new analytical method that sheds light on an enduring mystery regarding type 2 diabetes: Why some obese patients develop the disease and others don't.

6 Jun 2022

Link between COVID-19 severity and microbiome of saliva and nasopharynx

In a recent study posted to the bioRxiv* preprint server, researchers profiled the salivary and nasopharyngeal microbiomes of coronavirus disease 2019 (COVID-19) patients and determined the association between the microbiomes and COVID-19 severity.

6 Jun 2022

Study shows the two-way association between IBD and depression in siblings

Inflammatory bowel disease (IBD) is a chronic condition involving inflammation of the digestive tract, affecting some 1.6 million Americans. Depression affects more than 16 million Americans.

2 Jun 2022

Antibiotics ravage motivation and endurance in athletes

New research demonstrates that by killing essential gut bacteria, antibiotics ravage athletes' motivation and endurance.

1 Jun 2022

New study demonstrates the collapse of coalitions in microbial ecosystems

Government coalitions often dissolve when too many parties disagree on too many issues. Even if a coalition seems stable for some time, a small crisis can cause a chain reaction that eventually causes the system to collapse.

31 May 2022

New class of antibiotics found to be highly effective against drug-resistant tuberculosis

Infection by Mycobacterium tuberculosis kills 1.5 million people worldwide every year. Antibiotics to treat TB exist, but in recent years, multi-drug resistant (MDR), extensively drug-resistant (XDR) and totally drug-resistant (TDR) strains of the bacterium have developed.

31 May 2022